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ABSTRACT
The incidence of obesity in the U.S. is alarming. There are serious comorbid
conditions associated with morbid obesity. These include hypertension, diabetes type-2,
and sleep apnea. Although much money and effort is spent on weight loss programs,
only 5% of the people meet with success.
This study is a retrospective examination of outcomes of a bariatric surgery
program. Charts were reviewed between the years of 2000 and 2003. The population
included over 100 patients who had Roux-en Y gastric bypass in a town in the Western
United States.
The variables examined were the resolution of hypertension, diabetes type-2, and
sleep apnea; weight loss trends; and incidence of complications. After Roux-en-Y gastric
bypass surgery weight loss was found to be significant. The comorbidities were reduced
postoperatively. Diabetes and hypertension were found to have statistically significant
reductions. Sleep apnea reduction was not found o be statistically significant. In all
complications examined, the incidence was higher than those found in the literature
except pneumonia and wound infection.

IX

CHAPTER 1
INTRODUCTION
The increasing incidence of obesity is so alarming in this country that the Centers
for Disease Control track it at an annual rate. Obesity is approaching epidemic
proportions in the United States and may soon pass cigarette smoking as the number one
killer of Americans. Over half of all Americans are overweight, and obesity has doubled
since 1960 (Reddy, Riker, Marra, Thomas & Brems, 2002). Major medical problems
associated with obesity include hypertension, diabetes, obstructive sleep apnea, and
degenerative joint disease (Ogunaike, Jones, Jones, Provost & Whitten, 2002).
Approximately 300,000 deaths per year occur due to obesity (Craig & Tseng, 2002). As
weight measured in body mass index (BMI) increases, the risk of associated comorbid
conditions also increases.
This great increase in the incidence has resulted in multiple measures aimed at
assisting people bring their weights’ down to more normal levels. One of the
interventions is surgical. Prior to surgical intervention for obesity, the National Institutes
of Health recommends a documented six-month medically directed attempt at weight
loss. The morbidly obese have had very little success with traditional forms of weight
loss. Less than five percent of patients who attempt medically directed and/or nonmedically directed forms of weight loss are successful. Most people who arrive for
gastric bypass surgery have spent years on diets, exercise, and medication to lose weight.
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People who do lose weight are rarely able to keep the weight off for any length of time.
Many people see surgery as their only option.
Purpose of the Study
The purpose of the study was to investigate outcomes of a bariatric surgery
program. The study examined resolution of obesity, resolution of comordities, incidence
of complications, and length of stay in patients who have had the Roux-en-Y surgical
intervention for obesity. It was expected that the trends of weight loss, comorbidity
resolution, and incidence of complications would be significant in patients after gastric
bypass surgery.
The Roux-en-Y gastric bypass is a very successful form of surgery for weight
loss. The patients typically lose over half of their weight and are able to keep from
regaining lost pounds for 10 years. There has been a dramatic decrease in comorbid
conditions associated with the surgery.
The bariatric surgery program being studied has been diligent in keeping medical
records, but individual variables have not been studied to date. It is the hope of the
researcher that studying these individual data and providing feedback will serve to assist
the program by identifying trends of weight loss, resolution of comorbidities, and
incidence of complications. This will be useful information to the bariatric program to
compare with data from other programs. This will allow the program to see how they
compare to national trends of weight loss, comorbidity resolution, and incidence of
complications and if they need to alter their program.
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Significance of the Study
Surgical intervention for weight loss has proven to be successful in long-term
weight loss and in resolution of comorbidities (Buchwald, 2002). People who undergo
gastric bypass surgery have usually attempted to lose weight by many other methods.
These methods include diet, exercise, and medically directed programs.
There is a strong correlation between obesity and comorbid conditions such as
diabetes, sleep apnea, and hypertension. As obesity increases, so does the risk of
developing these conditions (Ogunnaike et al., 2002). This study examined the extent of
comorbidity resolution in a group of patients who had surgery for obesity.
There are risks associated with the surgery. Some of these risks include would
infection, incisional hernia, pulmonary emboli, and pneumonia (Podnos, Jimenez,
Wilson, Stevens & Nguyen, 2003). This study examined the risks associated with the
Roux-en-Y gastric bypass surgery in a population in the Western United States.
Research Questions
The questions explored in this study were:
1. What is the trend of weight loss in patients who have undergone bariatric
surgery?
2. What is the rate of comorbidity resolution in a group of patients who have
undergone bariatric surgery?
3. What is the incidence of complications in a group of patients who have
undergone surgery for obesity?
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Theoretical Framework
The theoretical framework chosen for this study focuses on the physiology of
obesity. Obesity is the accumulation of an abnormally large amount of adipose tissue.
The most accurate way to quantify body weight is the body mass index (BMI) and it is
used extensively in epidemiological studies. BMI is calculated by dividing weight in
kilograms by height in meters squared. The 1995 guidelines from the National Institutes
of Health and the American Health Foundation stipulate that a BMI of less than 25 is
desirable. The World Health Organization recommends a BMI of less than 30 to avoid
major health risks associated with obesity (Hansen, 1998).
Obesity is a metabolic disease of the storage of lipids. Decreased lipid
utilization may be a result of physical activity or from genetic alterations in metabolic
rates. The state of positive energy balance results in fat deposition. Ingesting an excess
of calories also results in weight gain.
Obesity results in changes to the endocrine system. There is an increase in
cortisol, development of resistance to insulin, and a decrease in steroid and growth
hormones. The sympathetic system is altered which changes the stress response (Hanson,
1998). Specifically, high cortisol levels alter the stress response. A relationship has been
found between a hyperactive hypothalamic-pituitary axis and obesity (Gluck, Gelieber &
Lorence, 2004).
There are often cardiovascular, pulmonary, gastrointestinal and metabolic
changes associated with obesity. Increases in triglycerides, cholesterol, and liver
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transaminase serum levels are often seen. Increased blood volume, plasma volume, and
cardiac output causes elevated right atrial and pulmonary artery pressures. This results in
hypertension in 50% of obese people. The incidence of coronary artery disease is twice
that of the non-obese. Fat metabolism increases oxygen consumption and carbon dioxide
production. Chest wall compliance is decreased. The combination of decreased chest
wall compliance and increased carbon dioxide production increase the energy
expenditure and necessary minute volume required for maintenance of normal carbon
dioxide levels. Obesity can cause restrictive lung disease. There is three times the risk of
gallbladder disease and biliary tract disease in the obese population (Faust, 2002).
Obesity in this country has been on the rise for years (Gregg et al., 2005). The
prevalence of obesity in the United States was constant from 1960 to 1980. The end of
the 1980's showed a measurable increase in prevalence that has continued to increase to
the year 2000 (Flegal, Carroll, Ogeden & Johnson, 2000). Obesity has an impact on
society as well as the individual.
Obese patients have significant physical, emotional, social and spiritual
impacts. Some people not only have comorbid conditions associated with obesity, they
also have difficulty meeting their basic functional needs. Much of the course of a disease
is determined by how the person views the disease and its effect. These patients typically
have low self-esteem and depression (Livingston, 2003).

5

Definitions
Incidence of complications. For the purpose for this study, the complications
associated with bariatric surgery are limited to the following: splenectomy; anastomotic
leak; deep vein thrombosis; pulmonary emboli; bowel obstruction; length of hospital stay
greater than four days; and wound infection. These complications will be measured by
reviewing patients’ charts for notation of their presence. See appendix.
Bariatric surgery. A surgery designed to cause weight loss. There are many
techniques available. The patient population examined in this study has had the open
Roux-en-Y, which reduces the functional size of the stomach to approximately five
percent of the original size. The remainder of the stomach, all of the duodenum, and part
of the proximal jejunem are bypassed.
Weight loss. The loss of body weight measured in pounds and in body mass
index (BMI). The trend examined will be three months, six months, nine months, one
year, and two years from the time of surgery and will be measured by recorded values in
patients’ records.
Comorbidity resolution. Diabetes resolution was measured by noting both the
discontinuation of medications and/or reporting of normal blood glucoses. Sleep apnea
resolution was measured by cessation of the use of an assistive device such as continuous
positive airway pressure (CPAP) at night. People with sleep apnea use such devices to
increase their oxygenation during sleep. The resolution of hypertension was measured by
noting the discontinuation for medication and notation of blood pressures within normal
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limits. The normal limits are a systolic blood pressure less than 140 or a diastolic blood
pressure less than 90.
Assumptions
The assumptions of the study are:
1. The study will provide beneficial feedback to the bariatric program being studied by
providing data for them to compare their program with other national trends.
2. The charts will contain the variables being studied and will be accurately recorded.
Limitations
1. The patients’ charts may be incomplete as the bariatric surgery program changed
affiliation four to five years ago and the charting information were revised.
2. Findings of this study are limited to the sample being studied and thus cannot be
generalized.
3. There is no way to assure reliability of chart entries or their completeness.
4. The most complete charts will be found at the preoperative point in care. Complete
histories and lab values will be found prior to surgery.
5. All patients may not be compliant with follow-up examinations; thus, some of the data
may be incomplete.
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CHAPTER II
REVIEW AND CRITIQUE OF THE LITERATURE
Introduction
The purpose of this chapter is to review the literature related to the Roux-en-Y
gastric bypass. This is a surgical option for weight loss. The review examines
comorbidities associated with obesity and complications associated with the gastric
bypass procedure.
Obesity
Obesity is on the rise in the United States. Costs for treating obesity-associated
comorbidities in this country annually has been estimated to be more than $51 billion.
The annual cost for treatment of weight loss is more than $30 billion (Brolin, 2002).
There is a great deal of evidence in the literature related to obesity and associated
comorbidities. The risk of developing obesity related conditions increases as boy mass
index (BMI) increases. BMI is derived by dividing a person’s weight in kilograms by his
weight in meters squared. A BMI of 25-30 is considered low risk. A BMI of 30-34.9 is
considered to be a class 1. A class 2 is a 35-39.5 BMI; a BMI > 40 is very high risk and
is termed a class 3. The significance of class 3 obesity is that not only has the incidence
increased almost 3 fold from 1990 to 2000 in this country, the mortality risk is double
that of class 1 (Freedman, Khan, Serdula, Galuska & Dietz, 2002; Ogunnaike et al.,
2002 ).
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The National Institutes of Health recommends surgery for obesity if a BMI > 40
or if there is a BMI > 35 with existing comorbidities (Brolin, 2002; Ogunnaike et al.,
2002; Greenway, Greenway & Klein, 2002). Bariatric surgical procedures are a
successful method of weight loss as compared to alternative treatments (Greenway et al.,
2002). The success rate for medically directed weight loss programs is five percent or
less. Even when weight loss does occur, rarely does the patient maintain the lower
weight. Often this results in frustration for the patient. Surgical intervention for weight
loss has been proven to be successful both in long-term weight loss and resolution of
comorbidities. Bariatric surgery is becoming more commonplace and interest by the
public is on the rise. In 200, there were 40,000 bariatric surgical procedures performed
(Buchwald, 2002). In 2002, approximately 100,000 procedures were done. Most of
these surgical procedures were the Roux-en-Y gastric bypass (Ray, Nickels, Shariq &
Sax, 2003).
The Roux-en-Y gastric bypass provides a combination of gastric restriction with
some malabsorption. The upper five percent of the stomach is separated from the rest of
the stomach and a limb of the proximal jejunum is attached to the small upper stomach
pouch. This excludes most of the stomach, all of the duodenum, and part of the proximal
jejunum from digestion. Proteins, carbohydrates, and fats are absorbed but vitamin B12
and iron absorption is decreased (Brolin, 2002).

9

Weight loss after the Roux-en-Y gastric bypass can be quite dramatic. The
patients typically lose 50%-60% of their excess body weight in 2 years (Ogunnaike,
2002). This corresponds in a 10-point drop in BMI.
Comorbidities Associated With Obesity
Obesity is a risk factor for many conditions including type-2 diabetes,
hypercholesterolemia, stroke, heart disease, hypertension, obstructive sleep apnea,
obesity hypoventilation syndrome, cancer, arthritis, osteoarthritis, and infertility (Flegel,
Carroll, Ogden & Johnson, 2002; Garza, 2003). These comorbidities do respond to
weight loss.
For the purpose of this study, the comorbidities examined were type-2 diabetes,
sleep apnea, and hypertension. Not only are these conditions closely associated with
obesity, they also significantly increase the risk of cardiovascular disease.
Most people who have diabetes type-2 are obese (Greenway et al., 2002). The
two conditions are closely related. Insulin resistance is one of the major
pathophysiological effects of obesity. In the presence of increased adipose, there is
resistance by the peripheral tissue to the effects of insulin. Insulin resistance occurs when
there is a decreased sensitivity to insulin, serum glucose levels rise and type 2 diabetes
ensues (Hanson, 1998).
Weight loss has been shown to significantly decrease the progression of impaired
glucose tolerance that leads to diabetes (Long, O'Brien, Macdonald, Legget-Frazier,
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Swanson & Pories et al., 1994). Unfortunately successful weight loss is very difficult to
achieve in the obese population without some surgical intervention.
It has been shown that bariatric surgery has a positive impact on the resolution of
type-2 diabetes. In a 10-year study of over 450 patients, Pories et al. (1992) reported that
along with the control of weight, surgery also controlled, hyperglycemia,
hyperinsulinemia, and insulin resistance. Gastric bypass surgery has been associated
with an 80-90% resolution of type-2 diabetes in cases of early diagnosis (Ferchak &
Meneghuni, 2004).
Two recent studies examined the early hormonal changes after gastric bypass
surgery. Rubino et al. (2004) studied changes in hormones after roux-en-Y gastric
bypass. The study showed significant changes and normalization of glucose and insulin
levels before significant changes in BMI. Clements et al. (2004) measured hormone
levels at two weeks, six weeks, and twelve weeks. Whereas glucose levels decreased
significantly, insulin levels approached but did not achieve significance over twelve
weeks. Although findings were different, both studies showed changes in hormone levels
prior to changes in BMI.
Obstructive sleep apnea is a disruptive as well as a life threatening illness. There
are frequent arousals during sleep and patients often experience hypoxia and high carbon
dioxide levels. Upper airway occlusion may occur (Hansen, 1998). Increased obesity,
especially central or upper body obesity, increases the risk of sleep apnea (Dixon,
Schachter & O’Brien, 2003).
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It is estimated that five percent of obese patients develop obstructive sleep apnea.
Obese people have increased adipose in the neck and pharyngeal tissues, which causes
airway narrowing. The pharyngeal airway stays open in awake individuals because of the
dilator muscle. Muscle tone is decreased during sleep and airway collapse ensues.
Hypercarbia, hypoxia, and the increased work of breathing awaken the individual. The
airway tone is then restored as the person awakens (Stoelting & Dierdorf, 2002).
Sleep apnea can be obstructive, central, or mixed. Obstructive sleep apnea occurs
when respiratory effort persists despite occlusion of the oropharynx. Central sleep apnea
occurs when the respiratory efforts cease. Mixed central/obstructive sleep apnea occur as
a result of the combination of the two types (Qasin, Moonja & Tomashefski, 1997).
Obstructive sleep apnea is usually limited to times of sleep. The patient is able to protect
his airway during the day. As the condition develops, there may be apnic episodes
without respiratory effort. This central apnea is due to the progressive inability of the
respiratory system to respond to high levels of carbon dioxide.
Standard treatment for obstructive sleep apnea patients who are obese is to
encourage weight loss (Piccarillo, Duntley & Schlotland, 2000). As previously stated,
obese patients have very little success with weight loss programs. Guardiano et al.
(2003) showed gastric bypass surgery to be associated with significant improvement in
obstructive sleep apnea (n=28). In a little over two years after surgery, the study showed
a seventy-five percent improvement in symptoms.
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Hypertension places patients at increased risk of cardiovascular and kidney
disease. As blood pressure goes up so does the risk of myocardial infarction, heart
failure, cerebral vascular accident, and kidney disease (Chobanian et al., 2003; Sugerman,
Wolfe, Sica & Clore, 2003). The Sugerman group reported that of over 1000 patients
treated surgically, 51% (n=l,025) had hypertension. Hypertension resolved in 69% of
those patients after gastric bypass surgery (Sugerman et al., 2003). In the Swedish Obese
Subjects study, there was a 42% resolution of hypertension 2 years after surgery for
obesity (Karason, Lindroos, Stenlof & Sjostrom, 2000).
Complications Associated With Bariatric Surgery
Surgical procedures do offer many patients the only chance for significant weight
loss. The literature is quite extensive in relation to weight loss and resolution of
comorbidities. The potential complications are also well described in the literature.
Open Roux-en-Y gastric bypass is the surgical intervention most commonly performed
for obesity. In a review of gastric bypass surgeries (n=2771) wound infection was
present in 4% of the cases; incisional hernia in 15% of the cases; splenectomy in 2% of
the surgical cases; anastromotic leak in 4% of cases; gastro-intestinal hemorrhage in 4%
of the cases; bowel obstruction in 5% of the cases; pulmonary emboli in 0.41% of cases;
and pneumonia in 0.41% of the cases (Podnos, Jimenez, Wilson, Stevens & Nguyen,
2003).
For the purpose of this study, the complications examined were incisional hernia,
gastrointestinal hemorrhage, splenectomy, anastomotic leak, pneumonia, deep vein
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thrombosis/ pulmonary emboli, bowel obstruction, wound infection, and extended
hospital stay.
Summary
Obesity is a very serious condition and it is on the rise nationally. Comorbid
conditions associated with obesity include hypertension, type-2 diabetes, and sleep apnea.
The Roux-en-Y gastric bypass is a surgery that has proven to be very successful for both
long and short-term weight loss. There are risks associated with a surgical method of
weight loss. The possible risks of surgery for weight loss includes splenectomy,
anastomotic leak, pneumonia, deep vein thrombosis/pulmonary emboli, bowel
obstruction, bowel obstruction, wound infection, and extended hospital stay.
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CHAPTER III

METHODOLOGY
Introduction
The purpose of the study was to investigate outcomes of a bariatric surgery
program. The demo graphic variables examined were age and gender. The study
examined weight loss, resolution of comorbidities, complications, and length of patient
stay.
This chapter outlines the steps, procedures, and strategies utilized for gathering
data for this retrospective descriptive study. The population, sample, study design, data
collection procedures, data analysis, instrument reliability, and validity, and the
protection of human subjects will be addressed. The research questions explored were:
1. What is the trend of weight loss in patients who have undergone bariatric
surgery?
2. What is the incidence of comorbidity resolution in a group of patients have
undergone bariatric surgery?
3. What is the incidence of complications of a group of patients who have
undergone surgery for obesity?
Population and Sample
The population was all patients who have had open Roux-en-Y bariatric surgery
in a medical center in the western United States during the years 2000-2003. This
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procedure was initiated in 2000. Patient charts between the years 2000-2003 were
reviewed thus the population and the sample are synonymous.
The inclusion sample and population of over 100 patients had open Roux-en-Y
surgery for obesity in a town in the west between 2000 and 2003. The center started
performing some of the Roux-en-Y cases laparoscopically in 2004. All the patients were
adults. The population includes both males and females. The patients were from the
town and outlying rural areas. All patients had surgery by one of two surgeons.
Study Design
The design for this study was descriptive and retrospective. Descriptive statistics
are used to examine individual variables and the relationships between variables (Gillis &
Jackson, 2002). Medical records of patients who have had bariatric surgery were
reviewed. Factors related to comorbidities, complications, weight and age were collected
from these records. See Appendix for the data collection tool.
Data Collection Methods
After review of the data collection format and instrument by a panel of experts,
data was collected from medical records. The information was recorded on a data
collection form designed by the researcher. See Appendix.
The patients who had surgery returned for office follow-up visits at three months,
six months, nine months, and one year, and two years. Data collected included weight
and BMI before surgery, and at three months, six months, nine months, one year, and two
years; age in years at the time of surgery; gender; blood pressure before surgery, and at
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three, six, and nine months, and at one, and two years; sleep apnea before surgery, and
after surgery at three, six, and nine months, and at one, and two years; diabetes type-2
before surgery, and after surgery at three, six and nine months, and at one and two years;
and the occurrence of complications including splenectomy, anastomotic leak,
pneumonia, deep vein thrombosis, pulmonary emboli, bowel obstruction, wound
infection, and length of stay greater than four days.
Instrument Reliability and Validity
Experts in the field of bariatric surgery assessed content validity. When
reviewing the tool utilized for this study, they were asked to judge relevance of content
and appropriateness of analysis method. The experts reviewing the tool include two
bariatric coordinators from different programs, and two bariatric surgeons. The data
collection form and proposed data analysis method were revised as needed before
collection of data. The final form may be found in Appendix.
Data Analysis
After collection, the data were statistically analyzed utilizing Statistical Package
for the Social Sciences (SPSS). SPSS has been used for processing data for the social
sciences and nursing since the 1960's (Gillis & Jackson, 2002).
Frequency Counts are provided displaying one-way frequency tables, which
include frequencies (counts) and percentages of variables. The frequencies give a
breakdown of the incidence of each variable.
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The chi-square test was utilized to test for significance. This was used to answer
the question of whether surgery had an effect on sleep apnea, diabetes, and hypertension.
For this study, a p-value of 0.1 was used to test for significance.
Protection of Human Subjects
Prior to implementation of this research, the University Institutional Review
Board and the Hospital Institutional Review Board approved the study. Upon receiving
approval and permission to conduct the study from both boards, the information was
gathered. Keeping the information in a locked the file for three years following
completion of the project will protect the confidentiality of all subjects. The data will be
destroyed after a three-year period. Only the researcher and the thesis committee
members will have access to the data. Upon completion of the study, results will be
shared with the institution.
The information was coded and at no time during the study were the data linked
to individuals. No identifying markers were placed on any documents. Once a chart was
examined, it was placed back on the shelf and not reviewed again. The data collection
tool place in a private room provided to the researcher by the bariatric surgery program.
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CHAPTER IV

RESULTS
Introduction
The purpose of this chapter is to report the results obtained by retrospective chart
review of patients who had open bariatric surgery in a Western United States institution.
Over one hundred charts from the years 2000 to 2003 were reviewed. The questions
answered were:
1.

What surgery is the trend of weight loss in patients who have undergone
bariatric surgery?

2.

What is the incidence of comorbidity resolution in a group of patients who
have undergone bariatric surgery?

3.

What is the incidence of complications of a group of patients who have
undergone surgery for obesity?
Demographic Results

The demographic variables examined were age and gender. The mean age was 46
Vi years and the range was from 18 years to 69 years. Of the 104 charts reviewed, there
were 21 males and 83 females. See Table 1.
To examine the trend of weight loss, the patients were weighed at three months,
six, months, nine months, one year, and two years. The data may be found in Table 2.
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Table 1. Demographics of the Sample

Gender

Count

%

Male

21

20.2

Female

83

79.8

104

100

Total
Age
Minimum

18

Maximum

69

Mean

46.5

The mean preoperative weight was 299 pounds. The mean preoperative BMI was
48. The mean weight at here months was 251 pounds and the mean BMI was 41. The
mean weight at six months was 218 pounds and the mean BMI was 36. The mean weight
in pounds at nine months was 198 pounds and the mean BMI was 40. The mean weight
at one year was 190 pounds and mean BMI was 31. The mean weight at two years was
185 pounds and the mean BMI was 30.
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Table 2. Weight Loss Trends at Various Points of Time

Preoperative

3 month

6 month

9 month

1 year

2 year

N

104

63

62

44

69

36

Minimum pounds

207

160

138

122

120

130

Maximum pounds

460

377

352

311

325

297

Mean pounds

299

251

219

198

191

185

Minimum BMI

35

28

22

21

20

20

Maximum BMI

77

63

59

45

48

44

Mean BMI

48

41

36

40

31

30

Comorbidity Resolution
Hypertension
Hypertension was measured by noting the discontinuation of anti-hypertensive
medication and the notation of blood pressure within normal limits. There was no
distinction made between moderate and severe hypertension.
Of the 104 patient charts reviewed, 64 patients or 62% had hypertension. Thirtyfive patients or 34% did not have hypertension. For five patients or 5% of the sample, it
could not be determined if hypertension was present. At the three-month mark, 16
patients or 44% of the patients had hypertension. At six months, of the 104 patients, 66
had no data. At nine months, five patients or 29% of the patients had hypertension and
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there was no data for 87 patients. At one year, 11 patients or 21% of the patients had
hypertension and 42 patients or 79% of the patients presented without hypertension. At
one year, 51 patients or 49% of the patients had no data. Two years postoperatively, five
patients or 19% of the patients did have hypertension. Twenty-one patients or 81% of
patients did not have hypertension. Seventy-eight patients or 75% had no data. See
Table 3.
Hypertension was reported in 62% of the patients preoperatively and at the end of
two years only 19% had hypertension. Although the sample is much smaller at the end of
two years, the decrease in hypertension is significant.
Table 3. Percentage of Patients with Hypertension
Hypertension

n

no

yes

Preoperative

99

33.6%

61.5%

3 months

36

56%

44%

6 months

38

66%

34%

9 months

17

71%

29%

1 year

53

79%

21%

2 years

26

81%

19%

A chi-square analysis was used to test the significance of the reduction in
hypertension postoperatively. A p-value of <0.1 was considered significant. The
reduction in hypertension was statistically significant at three months, six months, and
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nine months and one year. The reduction in hypertension was not found to be statistically
significant at two years. See Table 4.
Table 4. Analysis of Chi-square for Hypertension
n

Chi-square Value

p-value

3 months

36

12.6720

0.0004

6 months

38

5.8137

0.0159

9 months

17

2.9514

0.0858

1 year

53

4.2166

0.0400

2 years

26

2.4306

0.1190

Diabetes
Diabetes was present was in 30 patients or 29% of the patients, preoperatively.
Diabetes was not present in 72 patients or 69% of the patients preoperatively. Two
patients or 2% of the patients had no data. At three months 5 patients or 15% of the
patients had diabetes, 28 patients or 85% of the patients did not have diabetes, and 71
patients had no data reported. At six months, 2 patients or 6% of the patients had
diabetes, 34 patients or 94% did not have diabetes, and 68 patients had no data. At nine
months, 0% of the patients reported diabetes 100% had no diabetes. There was no data
available for 86 patients. At one year 2 patients or 4% of the patients had diabetes, 51
patients or 96 % had no diabetes, and 51 patients had no data. At two years, 1 patient or
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4% of the patients had diabetes, 25 patients or 96% of the patients had no diabetes, and
78 patients had not data. See Table 5.

Table 5. Percentage of Patients with Diabetes
n

no

yes

102

69%

29%

3 months

33

85%

15%

6 months

36

94%

6%

9 months

18

100%

0%

1 year

53

96%

4%

2 years

26

96%

4%

Hypertension
Preoperative

Diabetes was present in 29% of the population preoperatively. At the end of a
two year period diabetes was present in 4% of the population. Although the number of
patients is decreased from preoperatively to two years, the decrease in diabetes was found
to be significant at three month, six months, and one year. There was no statistical
significance found in the reduction of diabetes postoperatively at nine months and two
years. At nine months there were too few patients with data to compute an analysis. See
Table 6.
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Table 6. Analysis of Chi-square Values for Diabetes.

n

Chi-square Value

p-value

3 months

33

10.3125

0.0090

6 months

36

6.3529

0.0117

9 months

18

1 year

53

5.7899

0.0161

2 years

26

1.6640

0.1971

Sleep Apnea
Sleep apnea was present in 62 or 60% of the patients preoperatively. Thirteen
patients or 13% of the patients had not data regarding this condition, preoperatively. At
three months, 7 patients or 50% of the patients had sleep apnea and the same numbers did
not. Ninety patients had no data at three months. At six months 4 patients or 31% of the
patients had sleep apnea. Ninety-one patients had no data. At nine months, 5 patients or
100% of the patients had no sleep apnea. There was no data for 99 patients. At one year,
3 patients or 19% of the patients reported sleep apnea. Thirteen patients or 81% of the
patients had no sleep apnea. Eight-eight patients had no data. At two years 3 patients or
21% of the patients reported sleep apnea. Eleven patients or 79% of the patients reported
no sleep apnea. Ninety patients had no data.
See Table 7.
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Table 7. Percentage of Patients with Sleep Apnea

Hypertension

n

no

yes

Preoperative

91

27.9%

59.6%

3 months

5

50%

50%

6 months

l:3

69%

31%

9 months

5

100%

0%

1 year

H6

81%

19%

2 years

b4

79%

21%

Sleep apnea was present in 60% of the patients preoperatively. It was present in
3% of the patients at the end of two years. The number of patients sampled is much less
at each point in time postoperatively, the decrease in sleep apnea was not found to be
statistically significant with a chi-square analysis. At the nine month point there were to
few data entries to compute an analysis. See Table 8.
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Table 8. Analysis of Chi-square Values for Sleep Apnea.

n

Chi-square Value

p-value

3 months

33

5.60000

0.180

6 months

36

1.7333

0.1880

9 months

18

1 year

53

2.2154

0.1366

2 years

26

1.043

0.3075

Complications
Of the 104 patients in the study, seven patients or seven percent of the patients
had a length of stay greater than four days. Seventy patients or sixty-seven percent of the
patients did not stay in the hospital greater than four days. Twenty-seven patients or 26%
of the patients had no data regarding length of stay. Incisional hernia occurred in 16
patients or 16% of the patients. Fourteen patients or 14% of the patients lacked data
regarding incisional hernia. Gastrointestinal bleeding was reported in five patients or 5%
of the patients. There was no gastrointestinal bleeding in ninety-three patients or 90% of
the patients. There was no data on 6 patients or 6% of the patients. Splenectomy
occurred in 2 patients or 2% of the patients. Ninety-five patients or 92% of the patients
did not have splenectomy. Seven patients or 7% had no data. Anastomotic leak was
reported in four patients or 4 % of the patients. Ninety-three patients or 89% of the
patients reported no anastomotic leak. Seven patients or 7% of the patients had not data
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related to anastomotic leak. No patients developed pneumonia. Ninety-seven patients or
93% of the patients reported no pneumonia. No data was reported in 7 patients or 7% of
the patients. Deep vein thrombosis was reported in one patient of 1% of the patients.
There was no data related to deep vein thrombosis in seven patients or 7% of the patients.
There were no cases of pulmonary emboli. Ninety-seven patients or 93% of the patients
reported no pulmonary emboli. Seven patients or 7% of the patients had no data. Bowel
obstruction was reported in five patients or 5% of the cases. No bowel obstruction was
reported in 92 patients or 88% of the patients. No data was reported for 7 patients or 7%
of the patients. Wound infection was evident in 4 patients or 4% of the patients. No
wound infection was reported in 94 patients or 90% of the patients. Six patients or 6% of
the patients had no data. See Table 9.
Summary
After the Roux-en Y gastric bypass, weight loss was found to be significant. All
of the comorbidities (diabetes, sleep apnea, and hypertension) did decline
postoperatively. Reductions in diabetes and hypertension were found to be statistically
significant. Reductions in sleep apnea were not found to be statistically significant for
the population studied. In all complications except pneumonia and wound infection, the
incidence was higher than found in the literature.
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Table 9. Complications Following Bariatric Surgery
Occurrence

Complications

Incisional hernia

16%

Splenectomy

2%

Anastomotic leak

4%

Pneumonia

0%

Deep vein thrombosis

1%

Bowel obstruction

5%

Wound Infection

4%

Gastrointestinal bleed

5%

O
4^

7%

3
II

Length of stay greater than 4 days

/■

>9

CHAPTER V
DISCUSSION
Introduction
In this chapter the findings are reviewed and compared with those found in the
literature. These include weight loss trends, comorbidity resolution, and incidences of
complications.
Weight Loss Trends
Weight loss is one of the main goals for most patients presenting for gastric
bypass surgery. The trends of weight loss were significant for the population studied.
There was an overall mean decrease of 114 pounds. The mean decrease, in BMI, from
preoperatively to two years postoperatively. In the study by Reddy et al. (2002)
reviewing 103 cases of patients who had open Roux-en-Y, they found at five months
postoperatively, the mean weight loss to be 33%. The mean weight loss at six months for
the present study was 29%. At two years the mean weight loss was 39%. As Brolin
(2002) reports in his study, traditionally 50% of excess weight loss has been viewed as a
successful surgery.
Comorbidity Resolution
Comorbidity resolution was found to be significant at some points in time
postoperatively. There were statistically significant reductions in diabetes and
hypertension. The reductions in sleep apnea were not found to be statistically significant
postoperatively. The variables were not reported at each interval in over 50% of the
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sample. Either there were no patient visits or the records were not complete. As was
speculated before the study, it was difficult to find complete charts at all intervals. The
most complete charts were found at the preoperative period.
Hypertension was reported in 62% of the patients preoperatively. At the end of
two years, 19% reported hypertension. The data were available for a much smaller group
at the end of two years but the reduction in this variable is significant nonetheless. In
Brolin's study (2003) of 1,025 patients, 51% had hypertension preoperatively and 15%
had hypertension after one to two years.
Diabetes was present in 29% of the patients preoperatively. At the end of two
years, diabetes was present in 4% of the populations. The number of patients examined
at two years was much fewer than at the preoperative stage. The reduction in diabetes
was not found to be significant. Brolin also studied the resolution of diabetes. In his
study, 15 % of patients had diabetes preoperatively and 3# of the patients had diabetes.
Postoperatively. As stated earlier, the number of patients in this study with complete
date postoperatively was much fewer than preoperatively.
Sleep apnea was present in 60% of the patients preoperatively and in only 21% of
the patients at 2 years. The number of patients examined was much smaller and the
reduction was not found to be significant. There was no significance found in sleep
apnea reduction postoperatively. This was most likely due to the small numbers of
patients with complete data after surgery.
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In the Swedish Obese Subjects Study (Karason et al,; 2000), the frequencies of
hypertension, diabetes, and sleep apnea decreased significantly as compared to the nonsurgical control group. They reported a 42% reduction in hypertension, a 47% reduction
in diabetes, and a 65% reduction in sleep apnea from the preoperative time.
Complications
Length of stay greater than four days was present in 7% of the patients. This
indicates that 7% of the population had complications, which kept them in the hospital
longer then the usual length of stay of three days. Incisional hernia was present in 16%
of the patients. Gastrointestinal bleeding had a 4% incidence. Splenectomy occurred in
2% of the patients. Anastomotic leak occurred in 4% of the patients. Deep vein
thrombosis had a 1% incidence. There were no reports of pulmonary embolus. Bowel
obstruction occurred in 5% of the cases. Wound infection occurred in 4% of the cases.
Podno’s et al. (2003) studied patients (N=2.771) who had had open gastric Rouxen-Y. Splenectomy occurred in 0.41% of the patient, anastomotic leak in 1.68%,
gastrointestinal hemorrhage in 0.6%, wound infection 6.6%, bowel obstruction 2.1%, and
incisional hernia 8.6%.
The differences found between Podno’s group and the present study group may be
due to the smaller population. Podnos examined incidence of complications in 2.771
patients who had open gastric bypass. The group in this study contained 104 patients.
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The higher complication rates may also be related to surgical technique or infection
control at the institution studied.
Some of the patients had multiple complications at one time. There was no
distinction made for this in this study. For instance, a patient with an anastomotic leak,
which required a reoperation might have stayed greater than four days in the hospital
postoperatively.
Recommendations for Practice
In most fields of nursing, we come in contact with the public. It is imperative that
we have an acute understanding of the implications of obesity on patients’ health. As
stated earlier, obesity is second only to smoking as a cause of mortality in this country.
Nurses need to be aware of the many comorbidities associated obesity in order to prepare
for a compromised respiratory system during the patients time in the operating room
immediately postoperatively.
Recommendations for Education
It is clear that the incidence of obesity is on the rise in this country. It needs to be
taught a disease process in nursing school curriculums. The impact of excess weight on
the cardiac, respiratory, and endocrine systems has been discussed in this study and
should be addressed as part of nursing school curriculum.
Recommendations for Research
We know there is a problem with obesity in this country. The research should be
directed at successful prevention and successful treatment of obesity. Future areas of
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study might examine ways to decrease the risks associated with surgical intervention for
weigh loss. A registry to tract all the patients who have had and will have gastric bypass
would be valuable. With such a tool, he weight loss trends, incidences of complications
and the resolution of comorbidities could be carefully examined. The impact of obesity
of the individual is another potential area of research. Finally, the data should be
compared to the institutions overall incidence of infection as these data may greatly affect
postoperative complication rates.
Summary
The study of 104 patients supports the data that surgical intervention for obesity is
a successful option for weight loss. The surgery was found to positively impact the
coexisting diseases such as diabetes, hypertension, and sleep apnea. There are risks with
the surgery. The same risks found in the literature were found in the study group.
The theoretical framework associated wit this study focused on the physiology of
obesity. The cardiovascular, pulmonary, and endocrine systems change as a result of
excess body adipose. The study showed that many of the comorbid conditions can be
reversed with weight loss. The study did not show a statistically significant reduction in
sleep apnea, but it did show a statistically significant reduction in hypertension and
diabetes associated with weight loss after Roux-en-Y gastric bypass.
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APPENDIX
COLLECTION TOOL

Study Subject

C o llectio n T ool
3
m o n th s

p re o p e r a tiv e

Weight BMI
Weight pounds
Diabetes
Hypertension
Sleep Apnea
Length of stay greater than 4
days
Incisional hernia
Gastrointestinal bleed
Splenectomy
Anastomotic leak
Pneumonia
Deep vein thrombosis
Pulmonary emboli
Bowel obstruction
Wound infection
Gender
Age
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6
m o n th s

9
m o n th s

1 year

2 y e a rs
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